摘要 |
A compound represented by formula (I'): (see formula I') (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO2 group, or the like; R2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X1 represents O, -NR3-, or -S(O)r-; X2 represents a methylene group, O, -NR3-, or -S(O)r-; Q' represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.
|
申请人 |
MOCHIDA PHARMACEUTICAL CO., LTD. |
发明人 |
UCHIDA, HIDEHARU;KOSUGA, NAOTO;SATOH, TSUTOMU;HOTTA, DAIDO;KAMINO, TOMOYUKI;MAEDA, YOSHITAKA;AMANO, KEN-ICHI;AKADA, YASUSHIGE |